The University of Otago is New Zealand's most research intensive university. It is also the top-ranked university for research quality (based on PBRF evaluations).
The Big Data and Better Ageing Research group focuses on using “big data” to help understand, model and manage health conditions.
Biostatisticians in the University of Otago, Christchurch are involved in research, consultancy and teaching.
The C4 brings together all those managing patients with cancer, those researching cancer, together with support groups and NGOs, and the community. It is a virtual centre which aims to bring best care for cancer in our community, enhance relevant research and to de-mystify cancer and its treatment. Contributing organisations include the University of Otago, Christchurch, the CDHB, Canterbury University and the Cancer Society.
The Canterbury Rheumatology & Immunology Research Group undertakes research in the broad field of rheumatic diseases
Pharmacogenomics is the study of how genes influence a patient's responses to drugs.
The Centre for Free Radical Research consists of biochemists and cell biologists undertaking a range of interrelated research projects on aspects of oxidative stress and antioxidant action under the direction of Tony Kettle, Mark Hampton, Margreet Vissers and Christine Winterbourn.
The Centre is actively involved in research that advances nursing practice and improves health outcomes for patients nationally and internationally.
We have followed the health, education and life progress of a group of 1,265 children born in the Christchurch (New Zealand) urban region during mid 1977.
The Institute is a multidisciplinary research unit focusing on neurohumoral factors involved in the regulation of blood pressure and salt/water balance, particularly with respect to their role in the pathophysiology of heart failure.
Tissue engineering (TE) strategies which aim to combine patient’s own cells, biodegradable scaffolds and growth factors may offer considerable advantages over current surgical interventions used to repair or regenerate damaged tissues following trauma or disease.
The main research focus for the group is on the clinical application of pharmacology knowledge.
In the Eye Movement Laboratory we use a variety of methods to make digital recordings of saccades, smooth pursuit eye movements and nystagmus.
Research in the Gene Structure and Function Laboratory (GSFL) centers around the role of genetic variation in the development and treatment of disease.
The Christchurch General Practice Research Group focuses on clinical research, where the results can be directly translated into clinical practice.
Our main area of research interest is the immunobiology of cancer and leukaemia. Our long term aim is to develop better methods for the diagnosis and treatment of malignant disease.
This is a group of academic gerontologists and geriatricians with interests and enthusiasm in teaching, research and service related to care of older people.
The group has an active research programme on the molecular pharmacology and molecular pathology of various inflammatory conditions such as acute pancreatitis, polymicrobial sepsis and burns with the long-term goal of developing clinically effective therapeutic approaches.
The main themes are endocrine regulation of reproduction, female fertility, assessment of fetal welfare and gynaecological cancer.
The Liver Sieve research group has an interest in the fine vessels of the liver.
We are interested in the pathology of human tumours and in identifying the genetic changes that give rise to cancer. Our research focuses on the molecular regulation of tumour growth, metastasis and response to therapy.
The opening of the Māori/Indigenous Health Institute (MIHI) represents a major milestone in the development of Māori-focused teaching and research at the University of Otago, Christchurch.
Ongoing data is collected for both the (i) Fetal Medicine clinical unit which reviews women with complicated fetal problems or those at risk for them, and the (ii) Maternal Medical clinic where women attend with underlying medical problems.
Improving patient health outcomes with bench-to-bedside nutrient research.
Current studies include a psychotherapy treatment trial in depression, a psychotherapy trial in people with bipolar disorder, a comparison of three psychotherapies for binge eating, a social anxiety disorder study and a study on the genetics of depression and personality.
The Molecular Pathology Laboratory is one of the leading molecular diagnostic laboratories in Australasia.
A university-based National Centre dedicated to developing and promoting effective interventions for people with addiction and co-existing disorders related problems in Aotearoa New Zealand.
Experienced researchers and talented young students use sophisticated technologies to push back the boundaries of knowledge in brain disorders.
To find out more about MS in New Zealand, a team of researchers from the Universities of Otago and Canterbury are carrying out a national prevalence study in conjunction with the MS Society of NZ.
The department has had long established interests in paediatric urology especially reflux, community child health, SIDS, and neonatal research.
Ongoing research activities include respiratory medicine, gastroenterology, nutrition, neonatal medicine, infectious diseases and childhood cancer.
Public Health is the study and practice of preventing disease, prolonging life and promoting the health of the population through the organised efforts of society.
The Rural Health Academic Centre (RHAC), Ashburton focuses on rurally relevant and inter-professional research, education, clinical skills, and simulation training.
Including Emergency Medicine, General Surgery, Clinical Trials, Clinical Studies, Laboratory-based Research, Ophthalmology, Oral and Maxillofacial Surgery, Otolaryngology-Head & Neck Surgery, Paediatric Surgery, Plastic Surgery, Urology, Vascular Endovascular and Transplant Surgery (VETS)
We are particularly interested in the development, application and implementation of diagnostic tests that lead to real improvements in management, outcomes and surveillance of infections of global importance.